Diagnostics Industry Analysis
Explore your competitors and realise your potential in the Diagnostics market. Our reports include information on Testing, Companion Markets, Imaging and In Vitro Diagnostics.
RSS
previous
| Diagnostic Substances (Global) - Industry Report (PMW07978) Plimsoll's Diagnostic Substances (Global) analysis is the most definitive and accurate study of the Diagnostic Substances (Global) sector in 2013. The report is split into two sections and uses both a... | May 2013 | £950€1,125$1,479 |
| Molecular Diagnostics -Technologies, Markets and Companies (JAI00051) Benefits of this report This report has evolved during the past 17 years, profiting from feedback by numerous readers and experts. The most comprehensive and up-to-date one-stop source of information on technical... | May 2013 | £3,535€4,187$5,500 |
| MEDICAL DIAGNOSTICS (Spain) - Industry Report (PMW08651) Plimsoll's MEDICAL DIAGNOSTICS (Spain) analysis is the most definitive and accurate study of the MEDICAL DIAGNOSTICS (Spain) sector in 2013. The report (compiled in Spanish language) is split into two sections... | May 2013 | £520€616$809 |
| MEDICAL DIAGNOSTICS (Italy) - Industry Report (PMW08650) Plimsoll's MEDICAL DIAGNOSTICS (Italy) analysis is the most definitive and accurate study of the MEDICAL DIAGNOSTICS (Italy) sector in 2013. The report (compiled in Italian language) is split into two sections... | May 2013 | £520€616$809 |
| Medical Diagnostics - Industry Report UK (PMS01261) Plimsoll Publishing's UK Medical Diagnostics Analysis provides a detailed overview of the UK Medical Diagnostics market and delivers a comprehensive individual analysis on the top 140 companies, including BMI HEALTHCARE... | May 2013 | £350€415$545 |
| In Vitro Diagnostics Markets in China (AMI00427) China's demand for in vitro diagnostics has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This... | May 2013 | £1,285£2,570€1,522€3,044$2,000$4,001 |
| Cancer Diagnostic Testing World Markets (TRI00145) Cancer testing is one of the most important growth opportunities for the next three to five years in the diagnostics segment. The National Cancer Institute estimates that about ten million... | May 2013 | £2,185€2,588$3,400 |
| 2013 U.S. Diagnostic Imaging Centers Industry-Industry & Market Report (BAS02216) The U.S. Diagnostic Imaging Centers Industry-Industry & Market Report, published annually by Barnes Reports, contains timely and accurate industry statistics, forecasts and demographics. The report features 2013 current and 2014 forecast... | Apr 2013 | £96€114$149 |
| Molecular Diagnostics Market & Forecast (RNR00004) (By Application, Technology, Countries, Companies & Clinical Trials) to 2017: Global AnalysisGlobal Molecular Diagnostics Market & Future Forecast to 2017 Overview The global molecular diagnostics market is witnessing a period of profound growth. The growth is coming from different regions and markets.... | Apr 2013 | £900€1,066$1,400 |
| Molecular Diagnostics in Cancer Testing (TRI00146) Molecular diagnostics is a rapidly-advancing area of research and medicine, with new technologies and applications being continually added. The technologies that come under the umbrella of molecular diagnostics include first-generation... | Apr 2013 | £2,185€2,588$3,400 |
| Global Smart Pill Technology Market (INF02342) 2012-2016TechNavio's analysts forecast the Global Smart Pill Technology market 2012-2016 to grow at a CAGR of 6.9 percent over the period 2012-2016. One of the key factors contributing to this... | Mar 2013 | £1,285€1,522$2,000 |
| Histone Methyltransferases: Global Markets for Research Tools, Diagnostics and Drug Discovery (BCC00645) REPORT HIGHLIGHTS This report provides: An overview of the global market and commercial potential for histone methyltransferases (HMTs) Analyses of global market trends, with data for 2012, estimates for 2013, and projections of... | Mar 2013 | £3,500€4,145$5,450 |
| Drugs and Diagnostics for Hematological Disorders: Global Markets (BCC00640) REPORT HIGHLIGHTS This report provides: An overview of the global market for drugs and diagnostics for hematological disorders. Analyses of global market trends, with data from 2010 through 2012, and projections of compound... | Mar 2013 | £3,500€4,145$5,450 |
| Research on China's FISH Probe (Fluorescent in Situ Hybridization Probe) Industry (HUI00128) 2013-2017: Pharmaceuticals and HealthcareAccording to Huidian's market research, the output value of China's FISH probe market in 2012 was about CNY 20 million to CNY 30 million; with the improvement of people's living... | Mar 2013 | £1,605€1,901$2,500 |
| Hemoglobin A1c Testing Markets (TRI00140) Hemoglobin A1c (HbA1c) testing is the most recent major technology to have entered the diabetes testing market. As the global prevalence of diabetes mellitus continues to increase rapidly, with more... | Mar 2013 | £2,185€2,588$3,400 |
| Infectious Diseases Point of Care Diagnostics - Products, Players and Outlook to 2017 (ESP00813) Summary The market for Point-of-Care (POC) diagnostic products used in infectious diseases is expected to exceed US$1.8 billion by 2017, with year-on-year double digit growth from 2013 onwards. META Description With the variable... | Feb 2013 | £895€1,060$1,393 |
| Global Flow Cytometry Market (INF02314) 2012-2016TechNavio's analysts forecast the Global Flow Cytometry market to grow at a CAGR of 10.82 percent over the period 2012-2016. One of the key factors contributing to this market growth... | Feb 2013 | £1,285€1,522$2,000 |
| Drivers of M&A in 2013-2016: PI3Ks and BTK Inhibitors - Part I (MPS00056) PI3K inhibitors and clinical data of Bendamustine +other drugs in chronic lymphocytic leukemia (CLL) and other leukemias were the flavor at ASH ‘12 and at the 31st JP Morgan Healthcare... | Feb 2013 | £965€1,143$1,500 |
| Global In Vitro Diagnostics (IVD) Market Report (KOA04336) 2012 EditionIn-vitro diagnostic (IVD) tests are intended to perform examination of specimens, including blood and tissue donations, derived from the human body, solely or principally for the purpose of providing information... | Feb 2013 | £515€610$800 |
| In-Vitro Diagnostics Market Analysis to 2017 (RCS00425) The global in-vitro diagnostics (IVD) market is going through a very exciting phase, offering immense opportunities for players involved in the business. The market, which on one hand, is struggling... | Feb 2013 | £965€1,143$1,500 |
| In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade (SUU00197) 2013 EditionThis latest In-Vitro Diagnostic Substance Manufacturing Industry report provides the most updated market research on the industry. Its scope contains analysis on the industry's key financial data, competitive landscape,... | Feb 2013 | £515€610$799 |
| Point of Care Testing Market and Forecast to 2016: Global Analysis (RNR00057) Point of Care Testing Market Overview The concept of Point of Care Testing (POCT), also known as bedside, near-patient testing and decentralized testing, relates to tests that are conducted by clinical... | Jan 2013 | £820€971$1,275 |
| New Zealand In Vitro Diagnostics Market Outlook to 2018 (GDA34337) Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology CultureNew Zealand In Vitro Diagnostics Market Outlook to 2018 - Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture Summary GlobalData's new report, New Zealand In... | Jan 2013 | £1,605€1,901$2,500 |
| World Market for Molecular Diagnostics(Infectious Disease, Oncology, Blood Screening, Pre-Natal and Other Areas) (KAL00003) 5th. Edition Molecular diagnostics is becoming a dominant platform in clinical medicine and represents one of the fastest growing segments of the IVD market. As analyst Shara Rosen, R.T., MBA. details, in... | Jan 2013 | £2,890€3,423$4,500 |
| Emerging Diagnostic Technologies in the Changing U.S. Market (BCC00580) Report Highlight This report provides: An overview of emerging diagnostic technologies, emphasizing the U.S. market in the context of efforts to rein in the cost of healthcare through improved diagnosis and early... | Jan 2013 | £3,500€4,145$5,450 |
